Skip to playerSkip to main contentSkip to footer
  • 9/1/2021
BioNTech ($BNTX@Germany) is trading higher today after announcing a collaboration with Pfizer ($PFE@US) to develop a vaccine to fight the Covid-19 Delta variant. BioNTech's stock is traded on the NASDAQ, and it was up 2.92% at press time.

Recommended